Attached files

file filename
EX-99.1 - EX-99.1 - NOVELION THERAPEUTICS INC.c20533exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2011
QLT Inc.
(Exact name of registrant as specified in its charter)
         
British Columbia, Canada   000-17082   N/A
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
887 Great Northern Way, Suite 101,
Vancouver, B.C. Canada,
   
V5T 4T5
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (604) 707-7000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 2.02 Results of Operations and Financial Condition.
On July 28, 2011, QLT Inc. reported its financial results for the second quarter ended June 30, 2011 and provided an update on its product pipeline. The full text of the press release announcing such results is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of QLT Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
         
Exhibit No.   Description
       
 
  99.1    
Press Release of QLT Inc. dated July 28, 2011.

 

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  QLT INC.
 
 
Date: July 28, 2011  By:   /s/ Cameron Nelson    
    Name:   Cameron Nelson   
    Title:   Senior Vice President, Finance and
Chief Financial Officer 
 

 

 


 

         
Exhibit Index
         
Exhibit No.   Description
       
 
  99.1    
Press Release of QLT Inc. dated July 28, 2011.